Micro Interactive Virtual Presentations

Share

Program Content

Activities

  • 1L Therapy for mPanC
    Current Therapeutic Options for Metastatic Pancreatic Cancer: First-line Treatment
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 17, 2021

    Expires: February 16, 2022

  • 2L Therapy for mPanC
    Current Therapeutic Options for Metastatic Pancreatic Cancer: Second-line Treatment
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 19, 2021

    Expires: February 18, 2022

  • Neoadjuvant/Adjuvant
    Neoadjuvant and Adjuvant Therapy Strategies for Patients With Resectable Pancreatic Cancer
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 01, 2021

    Expires: February 28, 2022

  • PARPi Maintenance
    The Emerging Role of PARP Inhibitors in the Maintenance Setting for Patients With Advanced Pancreatic Cancer
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 05, 2021

    Expires: March 04, 2022

Faculty

cover img faculity

Andrew H. Ko, MD

Associate Professor
Department of Medicine
Division of Hematology/Oncology
University of California, San Francisco
San Francisco, California

cover img faculity

Paul E. Oberstein, MD

Assistant Professor of Medicine
Division of Hematology/Medical Oncology
NYU Langone Health
Director, GI Medical Oncology
NYU Perlmutter Comprehensive Cancer Center
NYU Langone Healthy
New York, New York

Provided by

ProCE Banner

Supporters

Bristol Myers Squibb

Ipsen Biopharmaceuticals Inc